We need to learn what companies need in terms of Regulatory Science and what products are in the preclinical area that will require new concepts in Regulatory Science.
How likely is this idea to be implemented? Is the timing right? Are the necessary resources and support available?
Successfully implemented, how much of an impact will this idea make in addressing the challenge?
How different is this idea from what has already been tried or proposed?